Seems like a good result - outlook suggests more of the same or better. A repeat second half would put it on a P/E of 7.4. Good value and growth looks a winner for now.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025